The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Heterologous Expression of the Enterococcal vanA Operon in Methicillin-Resistant Staphylococcus aureus
Abstract
Two methicillin- and vancomycin-resistant Staphylococcus aureus strains, MI-VRSA and PA-VRSA, and Enterococcus faecalis DMC83006B, considered to be the potential donor of glycopeptide resistance to MI-VRSA, were studied. MI-VRSA is highly resistant to both glycopeptides, whereas PA-VRSA displays low-level resistance to vancomycin and reduced susceptibility to teicoplanin. We have analyzed the expression of the vanA operon in the three clinical isolates. Determination of the relative amounts of late peptidoglycan precursors and quantification of the d,d -peptidase activities, in the absence or after induction by glycopeptides, revealed that the resistance genes were expressed at similarly high levels in the three strains. Glycopeptide resistance stability in the three strains was studied by replica plating. Resistance was lost at high frequency, ca. 50%, after overnight growth of PA-VRSA in the absence of antibiotics, whereas it was fully stable in MI-VRSA and E. faecalis DMC83006B. Induction of resistance by vancomycin was significantly delayed in PA-VRSA relative to MI-VRSA. Low-level glycopeptide resistance of S. aureus PA-VRSA is thus likely due to instability of the genetic element, plasmid or transposon, carrying the vanA operon associated with a longer lag phase before growth resumes after induction by vancomycin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while the one originating from Pennsylvania (PE-VRSA) showed resistance only to vancomycin and easily lost the plasmid with the VanA operon [80].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Reynolds, P. E. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967563 · Cited by 699
Arthur, M., Molinas, C., & Courvalin, P. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.8.2582-2591.1992 · Cited by 338
Self-citation
Research works printed but not linked: 27
- 10.1128/AAC.37.8.1563 · DOI · Paper page
- 10.1016/0378-1119(94)00851-I · DOI · Paper page
- 10.1046/j.1365-2958.1996.00617.x · DOI · Paper page
- 10.1128/AAC.36.4.867 · DOI
- 10.1128/jb.175.1.117-127.1993 · DOI · Paper page
- 10.1128/AAC.45.2.375-381.2001 · DOI
- 10.1016/0966-842X(96)10063-9 · DOI · Paper page
- Berg, C. M., and D. E. Berg. 1995. Transposable elements as tools for molecular analysis in bacteria, p. 38-68. In D. J. Sherratt (ed.), Mobile genetic elements, 2nd ed. Oxford University Press, Inc., New York, N.Y.
- 10.1128/jcm.30.7.1654-1660.1992 · DOI · Paper page
- 10.1021/bi00107a007 · DOI · Paper page
- Centers for Disease Control and Prevention. 1997. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. Morb. Mortal. Wkly. Rep.46:626-628.
- 10.1128/CMR.10.4.781 · DOI · Paper page
- 10.1128/jcm.33.1.24-27.1995 · DOI · Paper page
- 10.1128/AAC.47.12.3954-3959.2003 · DOI
- 10.1128/AAC.39.11.2446 · DOI
- 10.1056/NEJM199808203390806 · DOI · Paper page
- Messer, J., and P. E. Reynolds. 1992. Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci. FEMS Microbiol. Lett.73:195-200.
- Miller, D., V. Urdaneta, A. Weltman, and S. Park. 2002. Vancomycin-resistant Staphylococcus aureus.Morb. Mortal. Wkly. Rep.51:902.
- 10.1099/00221287-147-9-2571 · DOI
- 10.1111/j.1365-2958.1994.tb00497.x · DOI · Paper page
- 10.1042/bj3010005 · doi:10.1042/bj3010005
- Sievert, D. M., M. L. Boulton, G. Stolman, D. Johnson, M. G. Stobierski, F. P. Downes, P. A. Somsel, J. T. Rudrik, W. Brown, W. Hafeez, T. Lundstrom, E. Flanagan, R. Johnson, J. Mitchell, and S. Chang. 2002. Staphylococcus aureus resistant to vancomycin. Morb. Mortal. Wkly. Rep.51:565-567.
- 10.1128/JCM.36.4.1020-1027.1998 · DOI · Paper page
- 10.1128/AAC.48.1.275-280.2004 · DOI · Paper page
- 10.1126/science.1090956 · DOI · Paper page
- 10.1021/bi00070a013 · DOI
- 10.1021/bi00008a008 · DOI
Cited by
Mechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Self-citationMechanisms of antimicrobial resistance in bacteria
Tenover, F. C. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.219 · Cited by 637
Cong, Y., Yang, S., & Rao, X. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2019.10.005 · Cited by 527
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Metadata
- Authors
- Périchon, B., & Courvalin, P.
- Affiliations
- Unité des Agents Antibactériens, Institut Pasteur, Paris, France
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2004-11
- Volume
- 48
- Issue
- 11
- Pages
- 4281-4285
- ISSN
- 0066-4804
- 1098-6596
- Cited by
- 44
- References
- 2
- Language
- en
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heterologous Expression of the Enterococcal vanA Operon in Methicillin-Resistant Staphylococcus aureus. https://app.cochat.ai/papers/10.1128/aac.48.11.4281-4285.2004
- The paper
- Périchon, B., & Courvalin, P. (2004). Heterologous Expression of the Enterococcal vanA Operon in Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.48.11.4281-4285.2004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.